Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells

Sarah A. Holstein, Raymond J. Hohl

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

Myeloma is characterized by the overproduction and secretion of monoclonal protein. Inhibitors of the isoprenoid biosynthetic pathway (IBP) have pleiotropic effects in myeloma cells. To investigate whether IBP inhibition interferes with monoclonal protein secretion, human myeloma cells were treated with specific inhibitors of the IBP or prenyltransferases. These studies demonstrate that agents that inhibit Rab geranylgeranylation disrupt light chain trafficking, lead to accumulation of light chain in the endoplasmic reticulum, activate the unfolded protein response pathway and induce apoptosis. These studies provide a novel mechanism of action for IBP inhibitors and suggest that further exploration of Rab-targeted agents in myeloma is warranted.

Original languageEnglish (US)
Pages (from-to)551-559
Number of pages9
JournalLeukemia Research
Volume35
Issue number4
DOIs
StatePublished - Apr 1 2011

Keywords

  • Apoptosis
  • GGTase II
  • Multiple myeloma
  • Secretion
  • Unfolded protein response

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Isoprenoid biosynthetic pathway inhibition disrupts monoclonal protein secretion and induces the unfolded protein response pathway in multiple myeloma cells'. Together they form a unique fingerprint.

  • Cite this